U.S. COMPANY FILING
ASTRAZENECA PRICES A $2BN BOND OFFERING
Filing text preview
AstraZeneca announced that its wholly-owned subsidiary AstraZeneca Finance LLC priced a $2bn three-tranche global bond offering on February 25, 2026, expected to close on March 2, 2026. Net proceeds will be used for general corporate purposes, possibly including refinancing. The issuance does not impact 2026 financial guidance.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record